Both in Pharmaceuticals
Aquestive Therapeutics vs Phathom Pharmaceuticals
Over the past year AQST returned −42.7% and PHAT returned −57.6%; their daily moves had a correlation of 0.19.
AQST −42.7% PHAT −57.6%Growth of $1, one year, split-adjusted
| Metric | AQST | PHAT |
|---|---|---|
| Price | $3.72 | $5.82 |
| Market cap | $466.9M | $472.7M |
| Today | −4.37% | +1.31% |
| 1 month | −18.2% | −16.0% |
| 6 months | −11.8% | −54.8% |
| Year to date | −42.4% | −64.9% |
| 1 year | −44.1% | −56.3% |
| Revenue growth (YoY) | +38.1% | +71.1% |
| Gross margin | 70.9% | 78.3% |
| Net margin | −165.5% | −16.4% |
| P/E (TTM) | — | — |
| Price / sales | 8.6× | 1.7× |
| Net cash | $47.8M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 57.2% | 71.6% |
| Short % of float | 25.6% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).